Healthcare Equipment and Supplies
Company Overview of Second Sight Medical Products, Inc.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. It offers Argus II System, an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. Second Sight Medical Products, Inc. sells its Argus II System to university hospitals, teaching hospitals, medical centers, and ambulatory surgical centers. The company was formerly known as Second Sight LLC. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Syl...
12744 San Fernando Road
Sylmar, CA 91342
Founded in 1998
Key Executives for Second Sight Medical Products, Inc.
Chief Financial Officer
Total Annual Compensation: $144.4K
Vice President of European Operations
Total Annual Compensation: $220.6K
Vice President of Manufacturing
Total Annual Compensation: $204.2K
Total Annual Compensation: $219.5K
Total Annual Compensation: $207.6K
Compensation as of Fiscal Year 2014.
Second Sight Medical Products, Inc. Key Developments
Second Sight Announces Exclusive Agreement with Tecnosalud S.A. to Bring the Argus II Retinal Prosthesis to Argentina
Feb 9 16
Second Sight Medical Products, Inc. announced plans to expand into South America by signing an exclusive agreement with Tecnosalud S.A. to distribute the Argus® II Retinal Prosthesis System (Argus II) in Argentina. Tecnosalud will be responsible for executing in-country management of all aspects of Second Sight's technology, including sales, marketing, national reimbursement, surgical and technical support. The Argus II is a device that induces visual perception in blind individuals with retinitis pigmentosa (RP) by providing electrical pulses to stimulate the retina's remaining cells, resulting in a perception of light patterns in the brain. Patients learn to interpret these light patterns to enhance their daily lives and visual function in a sighted world. There are an estimated 10,000 individuals in Argentina who are blind due to RP, with an additional 200 people newly diagnosed each year. Future enhancements to the Argus II will focus on external hardware improvements and software upgrades so that current Argus II users may benefit from the continually advancing technology.
Second Sight Medical Products, Inc. Announces the Resignation of Anne-Marie Ripley as Vice President, Regulatory & Clinical Affairs
Jan 6 16
Effective January 4, 2016, Anne-Marie Ripley resigned as Vice President, Regulatory & Clinical Affairs of Second Sight Medical Products, Inc. Ms. Ripley will continue to provide consulting services to the company under a 12 month consulting agreement pursuant to which Ms. Ripley has agreed to provide with her consulting services on an as needed basis through December 31, 2016.
Second Sight Medical Products, Inc. Presents at 27th Annual Piper Jaffray Healthcare Conference, Dec-02-2015 03:00 PM
Nov 24 15
Second Sight Medical Products, Inc. Presents at 27th Annual Piper Jaffray Healthcare Conference, Dec-02-2015 03:00 PM. Venue: Lotte New York Palace, New York, New York, United States. Speakers: Will McGuire, Chief Executive Officer, President and Member of The Board of Directors.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|